Reagan JL - Search Results

1

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.

Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Navarro JT, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M. Castillo JJ, et al. Among authors: reagan jl. Br J Haematol. 2019 Feb;184(4):679-682. doi: 10.1111/bjh.15156. Epub 2018 Mar 12. Br J Haematol. 2019. PMID: 29527667 Free article. Clinical Trial. No abstract available.

2

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.

Reagan JL, Castillo JJ. Reagan JL, et al. Expert Rev Anticancer Ther. 2011 Feb;11(2):151-60. doi: 10.1586/era.10.223. Expert Rev Anticancer Ther. 2011. PMID: 21342032 Review.

3

Plasmablastic lymphoma: a systematic review.

Castillo JJ, Reagan JL. Castillo JJ, et al. Among authors: reagan jl. ScientificWorldJournal. 2011 Mar 22;11:687-96. doi: 10.1100/tsw.2011.59. ScientificWorldJournal. 2011. PMID: 21442146 Free PMC article. Review.

4

Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies.

Castillo JJ, Reagan JL, Ingham RR, Furman M, Dalia S, Merhi B, Nemr S, Zarrabi A, Mitri J. Castillo JJ, et al. Among authors: reagan jl. Leuk Res. 2012 Jul;36(7):868-75. doi: 10.1016/j.leukres.2011.12.020. Epub 2012 Jan 29. Leuk Res. 2012. PMID: 22285508

5

Why is my patient neutropenic?

Reagan JL, Castillo JJ. Reagan JL, et al. Hematol Oncol Clin North Am. 2012 Apr;26(2):253-66, vii. doi: 10.1016/j.hoc.2012.02.003. Hematol Oncol Clin North Am. 2012. PMID: 22463826

6

Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies.

Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J. Castillo JJ, et al. Among authors: reagan jl. Blood. 2012 May 24;119(21):4845-50. doi: 10.1182/blood-2011-06-362830. Epub 2012 Apr 10. Blood. 2012. PMID: 22496152 Free PMC article.

7

Cellular immunotherapy for refractory hematological malignancies.

Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Reagan JL, et al. J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150. J Transl Med. 2013. PMID: 23782682 Free PMC article. Clinical Trial.

8

Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.

Pham A, Reagan JL, Castillo JJ. Pham A, et al. Among authors: reagan jl. Leuk Res. 2013 Oct;37(10):1229-32. doi: 10.1016/j.leukres.2013.07.014. Epub 2013 Aug 6. Leuk Res. 2013. PMID: 23932549 Review.

9

Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies.

Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Castillo JJ, et al. Among authors: reagan jl. Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):122-30. doi: 10.1016/j.clml.2013.10.005. Epub 2013 Nov 14. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24360912

10

Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always.

Gavini A, Reagan JL, Winer ES, Castillo JJ. Gavini A, et al. Among authors: reagan jl. Am J Hematol. 2014 Aug;89(8):853-7. doi: 10.1002/ajh.23660. Epub 2014 Apr 10. Am J Hematol. 2014. PMID: 24382755 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page